- Home
- REFI vs SMTI Comparison
REFI vs SMTI Comparison
Compare REFI & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REFI | SMTI |
|---|---|---|
| Founded | 2021 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 255.6M | 186.9M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | REFI | SMTI |
|---|---|---|
| Price | $13.13 | $24.22 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 2 |
| Target Price | $20.00 | ★ $41.00 |
| AVG Volume (30 Days) | ★ 119.8K | 43.8K |
| Earning Date | 11-04-2025 | 11-12-2025 |
| Dividend Yield | ★ 15.69% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | $54,287,847.00 | ★ $101,877,532.00 |
| Revenue This Year | $13.78 | $21.60 |
| Revenue Next Year | $4.07 | $16.70 |
| P/E Ratio | $7.75 | ★ N/A |
| Revenue Growth | N/A | ★ 30.52 |
| 52 Week Low | $11.85 | $18.90 |
| 52 Week High | $16.29 | $38.68 |
Technical Indicators
Market Signals| Indicator | REFI | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 55.08 | 50.89 |
| Support Level | $12.76 | $24.00 |
| Resistance Level | $13.25 | $25.41 |
| Average True Range (ATR) | 0.28 | 1.18 |
| MACD | 0.01 | 0.26 |
| Stochastic Oscillator | 56.18 | 44.86 |
Price Performance
Historical ComparisonAbout REFI Chicago Atlantic Real Estate Finance Inc.
Chicago Atlantic Real Estate Finance Inc is engaged in a commercial real estate finance company. Its primary investment objective is to provide attractive risk-adjusted returns for stockholders over time, through consistent current income dividends and other distributions and secondarily through capital appreciation.
About SMTI Sanara MedTech Inc.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.